Experience

White Fund SA

• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Executive Committee Member

  • Oct 2019 - Present

  Liège, Walloon Region, Belgium



Hersenletsel Liga vzw

• Belgium
• Non-profit Organizations
• 1 - 100 Employee

• Chair - Voorzitter

  • Dec 2019 - Present

  Brussels Area, Belgium



Minze Health

• Belgium
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Non Executive Director

  • Nov 2022 - Present

  Antwerp, Flemish Region, Belgium



RheaVita BV

• Belgium
• Mechanical Or Industrial Engineering
• 1 - 100 Employee

• Independent Director

  • Nov 2021 - Present

  Ghent, Flemish Region, Belgium



moveUP - digital therapies

• Belgium
• Hospitals and Health Care
• 1 - 100 Employee

• Non Executive Director

  • Feb 2021 - Present

  Brussels Metropolitan Area



Revalidatieziekenhuis Inkendaal

• Belgium
• Hospitals and Health Care
• 1 - 100 Employee

• Non Executive Director

  • Sep 2020 - Present

  St-Pieters-Leeuw, Flemish Region, Belgium



PharmaFluidics

• Non Executive Director

  • Apr 2020 - Nov 2020

  Ghent, Flemish Region, Belgium



ImmunXperts, a Q² Solutions Company

• Biotechnology Research
• 1 - 100 Employee

• Non Executive Director

  • May 2014 - Mar 2020

  Gosselies, Belgium Founder and non-executive board member. In March 2020, ImmunXperts became part of the Laval, Canada based CRO Nexelis Inc, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing.



MyCartis

• Belgium
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Interim CEO

  • Sep 2017 - Mar 2018

  Gent Area, Belgium



TRINEAN

• Chief Executive Officer

  • Mar 2012 - Jun 2017

  Gent Area, Belgium As CEO, I managed the recapitalisation of the company in 2012 and its subsequent exit in 2017. In 5 years, we built out a motivated and passionate team, driving the company to profitability while quintupling the revenues.



European Immunogenicity Platform

• Board Member

  • Sep 2006 - Dec 2016

  Belgium Founder (2006), President (2006-2012) and secretary general (2012-2017). The European Immunogenicity Platform acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity. Over 30 Biopharma members gather on a regular basis at symposia, working groups and other meetings to discuss and progress the assessment of Immunogenicity.



Lonza

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of Advanced Protein Services

  • Nov 2009 - May 2012



Algonomics

• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • Jun 1999 - Dec 2010

  CEO as from November 2007 Previously COO, head of finances, business development and IP, and actively implied in project management



essenscia

• Belgium
• Chemical Manufacturing
• 1 - 100 Employee

• Board Member

  • Mar 2008 - Mar 2010

  Brussels Area, Belgium

• President Bio.be

  • Mar 2005 - Mar 2010

  Brussels Area, Belgium



KeyGene

• Netherlands
• Biotechnology Research
• 100 - 200 Employee

• Director Bioinformatics

  • 2001 - 2003



ie-net ingenieursvereniging

• Belgium
• Non-profit Organizations
• 1 - 100 Employee

• Board Member

  • Mar 1998 - Mar 2000

  Antwerp Area, Belgium



PerkinElmer

• United States
• Biotechnology Research
• 700 & Above Employee

• IT Manager

  • Apr 1998 - Jun 1999

  Researcher in Bioinformatics IT Manager



European Young Engineers (EYE)

• Estonia
• Non-profit Organizations
• 1 - 100 Employee

• Secretary General

  • Dec 1994 - Dec 1998

  Antwerp Area, Belgium Co-Founder (1994) and secretary general (1995-1998).



Vrije Universiteit Brussel

• Belgium
• Research Services
• 700 & Above Employee

• Scientist

  • Sep 1991 - Mar 1998

  Bioinformatics developper and scientist. Research related with Immunology, Vaccination strategies, Epitope mapping and bioinformatics.